1
|
Jadhao NL, Musale HB, Gajbhiye JM, Humne VT. Copper-mediated [3 + 2] oxidative cyclization of oxime acetate and its utility in the formal synthesis of fentiazac. Org Biomol Chem 2024; 22:521-528. [PMID: 38087933 DOI: 10.1039/d3ob01882b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2024]
Abstract
A new protocol for the direct synthesis of 2-aminothiazole has been developed from oxime acetate and readily available sodium thiocyanate using a copper catalyst. The present transformation has good functional group tolerance. Various thiazoles were smoothly synthesized in good to excellent yields. The applicability of the present method has been extended to the formal synthesis of the non-steroidal and anti-inflammatory drug, fentiazac via the Sandmeyer reaction and Suzuki coupling.
Collapse
Affiliation(s)
- Nitin L Jadhao
- Organic Chemistry Division, CSIR-National Chemical Laboratory, Pune, 411008, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Harish B Musale
- Department of Chemistry, Shri R. R. Lahoti Science College, Morshi, 444905, India.
| | - Jayant M Gajbhiye
- Organic Chemistry Division, CSIR-National Chemical Laboratory, Pune, 411008, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Vivek T Humne
- Department of Chemistry, Shri R. R. Lahoti Science College, Morshi, 444905, India.
| |
Collapse
|
2
|
Barrionuevo E, Cornier PG, Delpiccolo CML, Mata EG, Roguin LP, Blank VC. Antiangiogenic activity of the penicillin derivative TAP7f in melanoma. J Mol Med (Berl) 2023; 101:249-263. [PMID: 36688961 DOI: 10.1007/s00109-023-02287-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2022] [Revised: 12/19/2022] [Accepted: 01/16/2023] [Indexed: 01/24/2023]
Abstract
Previously , we demonstrated that the non-antibiotic penicillin derivative TAP7f inhibited melanoma metastasis in vitro and in vivo through the downregulation of β-catenin and integrin αVβ3. As angiogenesis is required for tumor growth and metastasis, we decided to explore the possible antiangiogenic effect of TAP7f. We found that TAP7f inhibited proliferation, migration, tube formation, and actin cytoskeleton organization of human endothelial cells. In a gel plug assay, an in vivo model for angiogenesis, TAP7f also blocked vascular formation induced by fibroblast growth factor 2. Furthermore, when murine B16-F10 melanoma cells pre-treated with TAP7f were injected intradermally in mice, we observed a decrease in the number and thickness of the capillaries surrounding the tumor. Additionally, TAP7f downregulated vascular endothelial growth factor (VEGF) and platelet-derived growth factor-B (PDGF-B) expression in B16-F10 cells and VEGF receptor expression in HMEC-1 endothelial cells. When the antitumor effect of TAP7f was studied in C57BL/6 J mice challenged with B16-F10 melanoma cells, a significant reduction of tumor growth was observed. Furthermore, a decreased expression of VEGF, PDGF-B, and the endothelial cell marker CD34 was observed in tumors from TAP7f-treated mice. Together, our results suggest that the antiangiogenic activity of TAP7f contributes to its antitumor and antimetastatic action and positions this penicillin derivative as an alternative or complementary agent for the treatment of melanoma. KEY MESSAGES: • TAP7f inhibits proliferation, migration, tube formation, and actin cytoskeleton organization of endothelial cells. • TAP7f downregulates VEGF receptor expression in endothelial cells. • TAP7f downregulates VEGF and PDGF expression in melanoma cells. • TAP7f inhibits angiogenesis in vivo.
Collapse
Affiliation(s)
- Elizabeth Barrionuevo
- Laboratorio de Oncología y Transducción de Señales, Instituto de Química y Fisicoquímica Biológicas (IQUIFIB), Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina
| | - Patricia G Cornier
- Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Química Rosario (CONICET-UNR), Universidad Nacional de Rosario, Rosario, Argentina
| | - Carina M L Delpiccolo
- Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Química Rosario (CONICET-UNR), Universidad Nacional de Rosario, Rosario, Argentina
| | - Ernesto G Mata
- Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Química Rosario (CONICET-UNR), Universidad Nacional de Rosario, Rosario, Argentina
| | - Leonor P Roguin
- Laboratorio de Oncología y Transducción de Señales, Instituto de Química y Fisicoquímica Biológicas (IQUIFIB), Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina
| | - Viviana C Blank
- Laboratorio de Oncología y Transducción de Señales, Instituto de Química y Fisicoquímica Biológicas (IQUIFIB), Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina.
- , Buenos Aires, 956, C1113AAD, Argentina.
| |
Collapse
|
3
|
Li S, Zhang L, He Q, Zhang X, Yang C. Synthesis of 2-alkyl-chroman-4-ones via cascade alkylation-dechlorination of 3-chlorochromones. Org Biomol Chem 2021; 19:5348-5352. [PMID: 34042936 DOI: 10.1039/d1ob00463h] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An efficient and mild synthetic approach for 2-alkyl-substituted chroman-4-ones via zinc-mediated cascade decarboxylative β-alkylation and dechlorination of 3-chlorochromones was developed. This transformation employed commercially available starting materials and was performed under mild conditions without heat, visible light, peroxide or heavy metals. Moreover, various alkyl NHPI esters with functional groups and differently substituted 3-chlorochromones were tolerated, affording the targeted products with moderate to excellent yields. This protocol could be utilized to construct a diverse library of 2-substituted chroman-4-one derivatives, which could be useful in the discovery of lead compounds for drug discovery in the future.
Collapse
Affiliation(s)
- Shunyao Li
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China. and School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China
| | - Lanfei Zhang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
| | - Qian He
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
| | - Xiaofei Zhang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China.
| | - Chunhao Yang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China. and School of Pharmacy, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China
| |
Collapse
|
4
|
Spanò V, Barreca M, Rocca R, Bortolozzi R, Bai R, Carbone A, Raimondi MV, Piccionello AP, Montalbano A, Alcaro S, Hamel E, Viola G, Barraja P. Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors. Eur J Med Chem 2020; 212:113122. [PMID: 33401199 DOI: 10.1016/j.ejmech.2020.113122] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2020] [Revised: 12/15/2020] [Accepted: 12/18/2020] [Indexed: 10/22/2022]
Abstract
A series of [1,3]thiazolo[4,5-e]isoindoles has been synthesized through a versatile and high yielding multistep sequence. Evaluation of the antiproliferative activity of the new compounds on the full NCI human tumor cell line panel highlighted several compounds that are able to inhibit tumor cell proliferation at micromolar-submicromolar concentrations. The most active derivative 11g was found to cause cell cycle arrest at the G2/M phase and induce apoptosis in HeLa cells, following the mitochondrial pathway, making it a lead compound for the discovery of new antimitotic drugs.
Collapse
Affiliation(s)
- Virginia Spanò
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| | - Marilia Barreca
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| | - Roberta Rocca
- Dipartimento di Medicina Sperimentale e Clinica, Università Magna Græcia di Catanzaro, Viale Europa, 88100, Catanzaro, Italy; Net4Science srl, Academic Spinoff, Università Magna Græcia di Catanzaro, Viale Europa, 88100, Catanzaro, Italy
| | - Roberta Bortolozzi
- Istituto di Ricerca Pediatrica IRP, Fondazione Città della Speranza, Corso Stati Uniti 4, 35127, Padova, Italy
| | - Ruoli Bai
- Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, United States
| | - Anna Carbone
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| | - Maria Valeria Raimondi
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| | - Antonio Palumbo Piccionello
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| | - Alessandra Montalbano
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy.
| | - Stefano Alcaro
- Net4Science srl, Academic Spinoff, Università Magna Græcia di Catanzaro, Viale Europa, 88100, Catanzaro, Italy; Dipartimento di Scienze della Salute, Università Magna Græcia di Catanzaro, Viale Europa, 88100, Catanzaro, Italy
| | - Ernest Hamel
- Molecular Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, United States
| | - Giampietro Viola
- Istituto di Ricerca Pediatrica IRP, Fondazione Città della Speranza, Corso Stati Uniti 4, 35127, Padova, Italy; Dipartimento di Salute della Donna e del Bambino, Laboratorio di Oncoematologia, Università di Padova, via Giustiniani 2, 35131, Padova, Italy.
| | - Paola Barraja
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
| |
Collapse
|
5
|
CuSO4/sodium ascorbate catalysed synthesis of benzosuberone and 1,2,3-triazole conjugates: Design, synthesis and in vitro anti-proliferative activity. JOURNAL OF SAUDI CHEMICAL SOCIETY 2019. [DOI: 10.1016/j.jscs.2019.05.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
6
|
de Siqueira LRP, de Moraes Gomes PAT, de Lima Ferreira LP, de Melo Rêgo MJB, Leite ACL. Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues. Eur J Med Chem 2019; 170:237-260. [DOI: 10.1016/j.ejmech.2019.03.024] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 02/11/2019] [Accepted: 03/10/2019] [Indexed: 02/08/2023]
|
7
|
Zhang ZH, Wu HM, Deng SN, Chai RX, Mwenda MC, Peng YY, Cai D, Chen Y. Synthesis and biological evaluation of 2,4-disubstituted thiazole amide derivatives as anticancer agent. CHEMICAL PAPERS 2018. [DOI: 10.1007/s11696-018-0587-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
8
|
Kasaboina S, Bollu R, Gomedhika PM, Ramineni V, Nagarapu L, Dumala N, Grover P, Nanubolu JB. A green protocol for one pot synthesis of benzosuberone tethered thiadiazolopyrimidine-6-carboxylates using PEG-400 as potent anti-proliferative agents. Tetrahedron Lett 2018. [DOI: 10.1016/j.tetlet.2018.06.068] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Affiliation(s)
- Haider Behbehani
- Department of Chemistry, Faculty of Science, Kuwait University, Safat, Kuwait
| | - Kamal M. Dawood
- Department of Chemistry, Faculty of Science, Kuwait University, Safat, Kuwait
| | - Thoraya A. Farghaly
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt
- Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah Almukkarramah, Saudi Arabia
| |
Collapse
|
10
|
Marcoux D, Xiao HY, Murali Dhar TG, Xie J, Lehman-McKeeman LD, Wu DR, Dabros M, Yang X, Taylor TL, Zhou XD, Heimrich EM, Thomas R, McIntyre KW, Shi H, Levesque PC, Sun H, Yang Z, Marino AM, Cornelius G, D'Arienzo CJ, Gupta A, Pragalathan B, Rampulla R, Mathur A, Shen DR, Cvijic ME, Salter-Cid L, Lombardo LJ, Carter PH, Dyckman AJ. Identification of potent tricyclic prodrug S1P 1 receptor modulators. MEDCHEMCOMM 2016; 8:725-729. [PMID: 30108791 DOI: 10.1039/c6md00539j] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/26/2016] [Accepted: 11/21/2016] [Indexed: 12/31/2022]
Abstract
Recently, our research group reported the identification of prodrug amino-alcohol 2 as a potent and efficacious S1P1 receptor modulator. This molecule is differentiated preclinically over the marketed drug fingolimod (Gilenya 1), whose active phosphate metabolite is an S1P1 full agonist, in terms of pulmonary and cardiovascular safety. S1P1 partial agonist 2, however, has a long half-life in rodents and was projected to have a long half-life in humans. The purpose of this communication is to disclose highly potent partial agonists of S1P1 with shorter half-lives relative to the clinical compound 2. PK/PD relationships as well as their preclinical pulmonary and cardiovascular safety assessment are discussed.
Collapse
Affiliation(s)
- David Marcoux
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Hai-Yun Xiao
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - T G Murali Dhar
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Jenny Xie
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Lois D Lehman-McKeeman
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Dauh-Rurng Wu
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Marta Dabros
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Xiaoxia Yang
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Tracy L Taylor
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Xia D Zhou
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Elizabeth M Heimrich
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Rochelle Thomas
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Kim W McIntyre
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Hong Shi
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Paul C Levesque
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Huadong Sun
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Zheng Yang
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Anthony M Marino
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Georgia Cornelius
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Celia J D'Arienzo
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | | | | | - Richard Rampulla
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Arvind Mathur
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Ding Ren Shen
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Mary Ellen Cvijic
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Luisa Salter-Cid
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Louis J Lombardo
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Percy H Carter
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| | - Alaric J Dyckman
- Bristol-Myers Squibb Company , Princeton , New Jersey 08543-4000 , USA . ; ; Tel: +1 609 252 3980
| |
Collapse
|
11
|
Farghaly TA, Gomha SM, Dawood KM, Shaaban MR. Synthetic routes to benzosuberone-based fused- and spiro-heterocyclic ring systems. RSC Adv 2016. [DOI: 10.1039/c5ra26474j] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Benzosuberones are an important class of medicinal and pharmaceutical compounds and have recently attracted considerable attention. The present review highlights the progress in the synthesis of benzosuberones and their fused and spiro ring systems up to 2015.
Collapse
Affiliation(s)
| | - Sobhi M. Gomha
- Department of Chemistry
- Faculty of Science
- Cairo University
- Giza
- Egypt
| | - Kamal M. Dawood
- Department of Chemistry
- Faculty of Science
- Cairo University
- Giza
- Egypt
| | | |
Collapse
|
12
|
Behbehani H, Ibrahim HM, Dawood KM. Ultrasound-assisted regio- and stereoselective synthesis of bis-[1′,4′-diaryl-1-oxo-spiro-benzosuberane-2,5′-pyrazoline] derivatives via 1,3-dipolar cycloaddition. RSC Adv 2015. [DOI: 10.1039/c5ra02972d] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
A novel bis-[spiro-benzosuberane-2,5′-pyrazoline] derivatives were synthesized via 1,3-dipolar cycloaddition under ultrasonic irradiation.
Collapse
Affiliation(s)
| | | | - Kamal M. Dawood
- Chemistry Department
- Faculty of Science
- Kuwait University
- Kuwait
| |
Collapse
|